| 2-AG | 2-arachidonoylglycerol |
| AEA | Arachidonoylethanolamine/Anandamide |
| BDNF | Brain-derived neurotrophic factor |
| BMI | Body mass index |
| CB1; CB2 receptor | Cannabinoid receptor 1, 2 |
| CNS | Central nervous system |
| DAkkS | Deutsche Akkreditierungsstelle (German Accreditation Body) |
| DIN | Deutsches Institut für Normung (German Institute for Standardization) |
| DRKS | Deutsches Register Klinischer Studien (German Clinical Trials Register) |
| ECLIA | Electrochemiluminescence Immunoassay |
| ELISA | Enzyme-Linked Immunosorbent Assay |
| ECS | Endocannabinoid system |
| EOR | End of rehabilitation |
| EN | Europäische Normung (European Standadization) |
| FAAH | Fatty acid amino hydrolase |
| GPS | German Pain Society („Deutsche Schmerzgesellschaft e.V.“) |
| GPQ ("DSF") | German Pain Questionnaire („Deutscher Schmerzfragebogen“) |
| HPA | Hypothalamic–pituitary–adrenal |
| IGF-1 | Insulin-like growth factor 1 |
| IGF-1R | Insulin-like growth factor 1 receptor |
| ICD | International Classification of Diseases |
| ISO | International Organization for Standardization |
| DIN EN ISO 15189 | International Standard for Medical Laboratories |
| IL-6 | Interleukin-6 |
| IL-6R | Interleukin-6-receptor |
| LOCF | Last Observation Carried Forward |
| MHH | Medizinische Hochschule Hannover (Hannover Medical School) |
| MAGL | Monoacylglycerol lipase |
| NSAIDs | Non-steroidal anti-inflammatory drugs |
| NRS | Numeric rating scale |
| GPT | Global Performance of Treatment |
| Q-Q plots | Quantile-Quantile plots |
| SD | Standard deviation |